Blood test for early detection of bile duct cancer
Part of Cancer clinical trials.
This study is testing a new blood test to help find cholangiocarcinoma (bile duct cancer) earlier and more easily. If you are scheduled for surgery for this cancer, this test may help confirm the diagnosis without more invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have cholangiocarcinoma (bile duct cancer) that can be surgically removed
- You are generally well enough to manage daily activities (ECOG score 0-2)
- You have not had chemotherapy or targeted therapy for this cancer before the study
- You do not have any other type of cancer
- You are willing to give a blood sample before starting treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.
This trial tests whether a sample of bile (a fluid produced by your liver) can help doctors diagnose bile duct cancer more accurately. If you have a narrowing in your bile duct and need a procedure to take a tissue sample, you may be able to participate.
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
This study looks at a new way to detect bile duct cancer (cholangiocarcinoma) using samples taken during a routine ERCP. It tests a special protein marker that might help doctors diagnose the condition more accurately.
This study is testing a new lab technique to see if it can accurately diagnose a type of bile duct cancer called cholangiocarcinoma from stored tissue samples. It might help doctors diagnose this cancer more accurately in the future.
This trial uses a bile sample to help diagnose the cause of a bile duct stricture (a narrowing) that was not clearly identified by standard tests. It may help patients avoid more invasive procedures.
Hear when a new Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.